Skip to main content

The site uses cookies to help us provide you with the absolute best experience when you visit us. Read more about our cookie policy. By closing this message, you agree to our use of these cookies and that you have been informed.

Main navigation

Investors
About
News
Contact us
Egoo.health

en
sv

Main navigation

Investors
About
News
Contact us
Egoo.health

en
sv

Investors

+

Main navigation

Main navigation

News - Press releases
Financial Calendar
Financial reports
- IPO and listning documents
Corporate governance
Share information
Board
Management
Insiders
IR Contact
Presentations

Extraordinary general meeting January 2020

Protokoll - Extra stämma 13 januari 2020 (23MB)(Swedish)
Fullmaktsformulär.pdf
Fullständigt förslag till beslut om emission av units.pdf
Kallelse till extra bolagsstämma 13 januari 2020.pdf
Revisorns yttrande över styrelsens redogörelse för kvittning.pdf
Revisorns yttrande över styrelsens redogörelse för väsentliga händelser.pdf
Styrelsens redogörelse för kvittning.pdf
Styrelsens redogörelse för väsentliga händelser.pdf

Qlife

Qlife Holding AB
Hamntorget 3
SE-252 21 Helsingborg, Sweden
info@egoo.health

Links

About
Investors
Egoo.health

Qlife’s vision is to facilitate regular blood biomarker testing from home environment. We aim to make blood sampling convenient, cheap, fast, accessible and accurate resulting in more frequent blood testing to gain insight into personal health, with increased possibility for earlier discovery of illnesses. Our product is an integrated platform consisting of a small home device, disposable capsules each a test for a specific biomarker, and a digital infrastructure that shares data with patient journal or hospital platform.